G protein-coupled receptor class C group 5 member D = GPRC5D

• Rodriguez-Otero P, van de Donk NWCJ, Pillarisetti K, Cornax I, Vishwamitra D, Gray K, Hilder B, Tolbert J, Renaud T, Masterson T, Heuck C, Kane C, Verona R, Moreau P, Bahlis N, Chari A. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood Cancer J. 2024 Feb 2;14(1):24. doi: 10.1038/s41408-023-00966-9. Erratum in: Blood Cancer J. 2024 Mar 6;14(1):40. https://pubmed.ncbi.nlm.nih.gov/38307865/doi: 10.1038/s41408-024-01018-6. PMID: 38307865; PMCID: PMC10837198.

• Mei J, Cai Y, Jiang G, He Z, Wang R, Song C, Wan Y, Mao W. GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer. J Transl Med. 2023 Aug 13;21(1):542. doi: 10.1186/s12967-023-04415-w. PMID: 37574551; PMCID: PMC10424388.

Talquetamab (TALVEY®)